Barbara Capecchi, PhD GSK Vaccines

Barbara holds a masters degree in Biological Sciences from the University of Pisa and a PhD in Molecular and Cell Biology from the University of Padova, Italy.

Barbara started working at GSK Vaccines, formerly Chiron Vaccines in 1997, and spent 13 years in Pre-Clinical Research, focusing her research on the selection and functional characterization of bacterial and viral antigens, and the development of serological assays. In 2011, she joined the Analytical and Research Development team at GSK Vaccines in Italy leading efforts to develop and validate immunoassays and cell-based assays for measuring safety and potency attributes to support release and stability testing for clinical and commercial vaccines, with a focus on the replacement of in vivo with in vitro assays.